Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
291 participants
INTERVENTIONAL
2005-06-30
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Colorado Women's TC Project
NCT00249561
The Women's Recovery Group Study: Stage I Trial
NCT00230100
Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
NCT02293057
Opioid Use and Criminal Justice: Intervening to Improve the Outcomes of Women
NCT06682364
Drug Use Prevention Among Girls Through a Mother-Daughter Intervention
NCT00310258
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women-Only
Substance abuse treatment program for women only
Women-Only
Gender-responsive treatment for women only
Mixed-Gender
Substance abuse treatment program for both women and men
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Women-Only
Gender-responsive treatment for women only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least eighteen (18) years old
* Have had no more than three prior non-violent, non-drug felony convictions
* Do not have a current charge of driving under the influence of alcohol or drugs or a charge of sale or transportation of drugs
Exclusion Criteria
18 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Prendergast
Research Historian
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Prendergast, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California - Los Angeles
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Prendergast ML, Messina NP, Hall EA, Warda US. The relative effectiveness of women-only and mixed-gender treatment for substance-abusing women. J Subst Abuse Treat. 2011 Jun;40(4):336-48. doi: 10.1016/j.jsat.2010.12.001. Epub 2011 Feb 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDA-16277-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.